These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29309564)

  • 1. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing.
    Pablo Flórez J; García D; Valverde I; Rubín J; Pérez D; González-Vasserot M; Reguero J; María de la Hera J; Avanzas P; Gómez J; Coto E; Morís C; Calvo D
    Europace; 2018 Jun; 20(FI1):f64-f71. PubMed ID: 29309564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender difference in clinical and genetic characteristics of Brugada syndrome: SADS-TW BrS registry.
    Chen CJ; Juang JJ; Lin LY; Liu YB; Ho LT; Yu CC; Huang HC; Lin TT; Liao MC; Chen JJ; Hwang JJ; Chen WJ; Yeh SS; Yang DH; Chiang FT; Lin JL; Lai LP; Horie M;
    QJM; 2019 May; 112(5):343-350. PubMed ID: 30690642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
    Brugada J; Pappone C; Berruezo A; Vicedomini G; Manguso F; Ciconte G; Giannelli L; Santinelli V
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1373-81. PubMed ID: 26291334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance after cardiac arrest in patients with Brugada syndrome without an implantable defibrillator: An alarm effect of the previous syncope.
    Calvo D; Flórez JP; Valverde I; Rubín J; Pérez D; Vasserot MG; Rodríguez-Reguero J; Avanzas P; de la Hera JM; Gómez J; Coto E; Martínez-Camblor P; Morís C
    Int J Cardiol; 2016 Sep; 218():69-74. PubMed ID: 27232914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test?
    Zorzi A; Migliore F; Marras E; Marinelli A; Baritussio A; Allocca G; Leoni L; Perazzolo Marra M; Basso C; Buja G; Thiene G; Iliceto S; Delise P; Corrado D
    Heart Rhythm; 2012 Jun; 9(6):909-16. PubMed ID: 22334153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term flecainide therapy in type 3 long QT syndrome.
    Chorin E; Taub R; Medina A; Flint N; Viskin S; Benhorin J
    Europace; 2018 Feb; 20(2):370-376. PubMed ID: 28339995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Parianos D; Saguner AM
    Praxis (Bern 1994); 2017; 106(5):235-241. PubMed ID: 28253814
    [No Abstract]   [Full Text] [Related]  

  • 8. Time-dependent responses to provocative testing with flecainide in the diagnosis of Brugada syndrome.
    Calvo D; Rubín JM; Pérez D; Gómez J; Flórez JP; Avanzas P; García-Ruíz JM; de la Hera JM; Reguero J; Coto E; Morís C
    Heart Rhythm; 2015 Feb; 12(2):350-7. PubMed ID: 25460174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors.
    Okamura H; Kamakura T; Morita H; Tokioka K; Nakajima I; Wada M; Ishibashi K; Miyamoto K; Noda T; Aiba T; Nishii N; Nagase S; Shimizu W; Yasuda S; Ogawa H; Kamakura S; Ito H; Ohe T; Kusano KF
    Circ J; 2015; 79(2):310-7. PubMed ID: 25428522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clinical and genetic findings on the management of young patients with Brugada syndrome.
    Andorin A; Behr ER; Denjoy I; Crotti L; Dagradi F; Jesel L; Sacher F; Petit B; Mabo P; Maltret A; Wong LC; Degand B; Bertaux G; Maury P; Dulac Y; Delasalle B; Gourraud JB; Babuty D; Blom NA; Schwartz PJ; Wilde AA; Probst V
    Heart Rhythm; 2016 Jun; 13(6):1274-82. PubMed ID: 26921764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of clinical assessment and electrophysiology study in Brugada syndrome patients with syncope.
    Hernandez-Ojeda J; Arbelo E; Jorda P; Borras R; Campuzano O; Sarquella-Brugada G; Iglesias A; Mont L; Brugada R; Brugada J
    Am Heart J; 2020 Feb; 220():213-223. PubMed ID: 31864099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of spontaneous type I ECG pattern, syncope, and other risk markers in sudden cardiac arrest survivors with Brugada syndrome.
    Leong KMW; Ng FS; Jones S; Chow JJ; Qureshi N; Koa-Wing M; Linton NWF; Whinnett ZI; Lefroy DC; Davies DW; Lim PB; Peters NS; Kanagaratnam P; Varnava AM
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):257-264. PubMed ID: 30569504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is flecainide dangerous in long QT-3 patients?
    Beinart R; Michailidis A; Gurevitz OT; Glikson M
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):143-5. PubMed ID: 19140927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for cardiac events in patients with Brugada syndrome: A PRISMA-compliant meta-analysis and systematic review.
    Wu W; Tian L; Ke J; Sun Y; Wu R; Zhu J; Ke Q
    Medicine (Baltimore); 2016 Jul; 95(30):e4214. PubMed ID: 27472692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A.
    Kanters JK; Yuan L; Hedley PL; Stoevring B; Jons C; Bloch Thomsen PE; Grunnet M; Christiansen M; Jespersen T
    Circ J; 2014; 78(5):1136-43. PubMed ID: 24599044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes.
    Olde Nordkamp LR; Vink AS; Wilde AA; de Lange FJ; de Jong JS; Wieling W; van Dijk N; Tan HL
    Heart Rhythm; 2015 Feb; 12(2):367-75. PubMed ID: 25311410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single oral flecainide dose to unmask type 1 Brugada syndrome electrocardiographic pattern.
    Dubner S; Azocar D; Gallino S; Cerantonio AR; Muryan S; Medrano J; Bruno C
    Ann Noninvasive Electrocardiol; 2013 May; 18(3):256-61. PubMed ID: 23714084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brugada syndrome and p.E61X_RANGRF.
    Campuzano O; Berne P; Selga E; Allegue C; Iglesias A; Brugada J; Brugada R
    Cardiol J; 2014; 21(2):121-7. PubMed ID: 24142675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.